Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Hodgkin Disease 2Burkitt Lymphoma 2Uveal Melanoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Oligodendroglioma 1Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1HIV Infections 1Glioblastoma 1Astrocytoma 1

Interventions

Rituximab 21Cyclophosphamide 18Prednisone 14Doxorubicin 12Magnetic Resonance Spectroscopy 11Lenalidomide 11Vincristine 10Specimen Handling 10Biopsy 7Gemcitabine 6pembrolizumab 5obinutuzumab 5ibrutinib 5Oxaliplatin 5prednylidene 4polatuzumab vedotin 4glofitamab 4deltacortene 4Prednisolone 4Dexamethasone 4CT-P10 4venetoclax 3tafasitamab 3fludarabine 3acalabrutinib 3R-CHOP protocol 3Nivolumab 3Immunotherapy, Adoptive 3Etoposide 3selinexor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large B-Cell, Diffuse × Carmustine × 30 days × Clear all
NCT00641381 2026-05-04

Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

City of Hope Medical Center

Phase 1 Completed
25 enrolled
DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡